MarketPeel
Insider Trading Intelligence
JT

James Treco

TNXP
DIRECTOR · TONIX PHARMACEUTICALS HOLDING CORP. · CIK 0001766070
FILING MIX · LIFETIME92%/8%
BUYS
11
SELLS
1
TOTAL VALUE
$18.7K
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
22,700
AVG SELL PX
$0.30
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by James Treco, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+0.00%-12.47%-0.83%-11.64%-12.07%
14d3+0.00%-14.07%+0.62%-14.69%-10.09%
30d3+0.00%-19.17%+0.25%-19.41%-25.00%
60d3+0.00%-35.44%+1.14%-36.58%-30.38%
90d3+0.00%-43.13%+4.26%-47.38%-48.93%
180d3+66.67%+12.17%+11.19%+0.98%+24.64%
1y3(1 pending)+0.00%-26.79%+32.78%-59.57%-59.57%
2y3(1 pending)+0.00%-95.76%+23.75%-119.52%-119.52%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TNXP · 22,700 shares · as of May 12, 2026
0532,8751,065,7501,598,6252,131,500202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 1 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
22,70022,700May 12, 2026May 14, 2026View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASE
250$36.00$9.0K250Aug 20, 2025Aug 20, 2025View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
10,00010,000May 13, 2025May 15, 2025View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
SALE
0.02$0.30$00Feb 5, 2025Feb 28, 2025View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
104,621104,621May 23, 2024May 24, 2024View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
60,00060,000May 8, 2023May 10, 2023View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
2,131,5002,131,500May 9, 2022May 11, 2022View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
270,882270,882May 10, 2021May 12, 2021View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASE
5,500$0.89$4.9K10,000Aug 31, 2020Sep 1, 2020View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASE
4,500$1.06$4.8K4,500Aug 14, 2020Aug 17, 2020View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
112,500112,500May 4, 2020May 6, 2020View →
TNXP
TONIX PHARMACEUTICALS HOLDING CORP.
PURCHASEGRANT
Stock grant
6,0006,000Mar 16, 2020Mar 18, 2020View →
Other insiders · TNXP
Loading peer insiders…
About this filer
CIK 0001766070
ROLE
Director
PRIMARY
TNXP
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001766070DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback